Detection of hepatitis C virus in patients with terminal renal disease undergoing dialysis in southern Brazil: prevalence, risk factors, genotypes, and viral load dynamics in hemodialysis patients

• Published in: Virology journal Vol. 12; no. 1; p. 8
• Main Authors: Vidales-Braz, Beatris Maria, da Silva, Naylê Maria Oliveira, Lobato, Rubens, Germano, Fabiana Nunes, da Mota, Luiza Dias, Barros, Elvino JG, de Martinez, Ana Maria Barral
• Format: Journal Article
• Language: English
• Published: England Springer-Verlag 03-02-2015; BioMed Central Ltd; BioMed Central
• Subjects: Adult; Aged; Aged, 80 and over; Brazil - epidemiology; Care and treatment; Cross Infection - epidemiology; Diagnosis; dialysis; Enzyme-Linked Immunosorbent Assay; Female; Genetic aspects; Genotype; Health aspects; Hemodialysis; Hepacivirus - classification; Hepacivirus - genetics; Hepacivirus - isolation & purification; hepatitis C; Hepatitis C - epidemiology; Hepatitis C Antibodies - blood; Hepatitis C virus; Humans; Kidney diseases; Kidney Failure, Chronic - complications; Kidney Failure, Chronic - therapy; Male; Medical research; Medicine, Experimental; Middle Aged; patients; Peritoneal Dialysis - adverse effects; Prevalence; Prevalence studies (Epidemiology); public health; questionnaires; Renal Dialysis - adverse effects; Reverse Transcriptase Polymerase Chain Reaction; Risk Factors; RNA, Viral - blood; serology; Viral Load; virion; Brazil
• ISSN: 1743-422X; 1743-422X
• DOI: 10.1186/s12985-015-0238-z

Hepatitis C (HCV) is a serious public health issue, and it is estimated that 3% of the world’s population is infected. Patients in hemodialysis units have an increased risk for contracting HCV, and high prevalence rates have been found in hemodialysis units around the world. This study is aimed at determining the prevalence of HCV in patients with terminal chronic renal disease (tCRD) who have been submitted to hemodialysis and peritoneal dialysis in southern Brazil to characterize the most prevalent genotypes, the viral load, and possible risk factors and to assess the validity between the ELISA and RT-PCR detection methods. Of 320 patients from three dialysis units, 318 participated in this study. According to the medical records, 55 patients were reactive to HCV, as determined via ELISA. All 318 samples were submitted to RT-PCR and genotyped using an Abbott Realtime® m2000 system. Data obtained through a questionnaire and chemical variables were associated with the HCV. Results: The prevalence of HCV was 18.24% (58), and the concordance between the HCV serology and the RT-PCR was 94%. Three patients were diagnosed to be negative for HCV using the ELISA assay but positive when using RT-PCR. Genotype 1 was the most prevalent (46.7%) genotype, within which subtype 1a was the most frequent (74.1%). One of the risk factors associated with HCV infection was the length of time that the patient had been undergoing hemodialysis treatments (p < 0.001). Additionally, the viral load was found to vary when tested before and after hemodialysis (p < 0.001). Conclusion: The prevalence of HCV in dialysis units continues to remain high, indicating nosocomial contamination. RT-PCR detected the presence of the hepatitis C virus in patients with a non-reactive serology, which highlights the importance of performing molecular tests on dialysis patients. The variation in the viral load in patients submitted to hemodialysis indicates a possible destruction or gripping of viral particles to the dialyzer membrane.